Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)-Reference-Cited by-同舟云学术

Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)

Published:2015-05 Issue:9981 Volume:385 Page:1949-1956
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Wagenlehner Florian M,Umeh Obiamiwe,Steenbergen Judith,Yuan Guojun,Darouiche Rabih O

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study;Levy;Lancet Infect Dis,2012

2. Therapeutic challenges of urosepsis;Wagenlehner;Eur J Clin Invest,2008

3. Healthcare-associated urinary tract infections in hospitalized urological patients-a global perspective: results from the GPIU studies 2003–2010;Cek;World J Urol,2014

4. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010;Sievert;Infect Control Hosp Epidemiol,2013

5. Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study;Tandogdu;World J Urol,2014

Cited by 323 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P07 Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA): results on critical care patients from a multinational, multicentre, observational analysis;JAC-Antimicrobial Resistance;2024-08

2. Evaluation of Factors Predictive of Efficacy Among Patients With Complicated Urinary Tract Infection and/or Acute Pyelonephritis;Open Forum Infectious Diseases;2024-07-16

3. Effectiveness of novel β-lactams for Pseudomonas aeruginosa infection: A systematic review and meta-analysis;American Journal of Infection Control;2024-07

4. European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines;European Urology;2024-07

5. Urinary Tract Infection Treatment;Infectious Disease Clinics of North America;2024-06